Beijing has reached for its chequebook. The Chinese finance ministry is advancing a 360 billion yuan (€46.1bn) package to state-owned financial institutions, announced on Sunday through statements from the companies involved and reported by state news agency Xinhua. It is one of the larger interventions in China's financial system this year as growth slows.
The banks take the bulk of the injection, roughly 290 billion yuan (€37.2bn), intended to preserve their capacity to keep lending as Beijing presses them to increase support for economic activity. Xinhua reported the injection would strengthen the institutions' "sound operating capabilities, risk resistance capabilities and ability to serve the real economy."
The Agricultural Bank of China is pursuing a private placement of A-shares worth up to 160 billion yuan (€20.5bn) and the Industrial and Commercial Bank of China up to 100 billion yuan (€12.8bn), with the finance ministry among the investors. Unusually, so is the China National Tobacco Corporation, which operates the state tobacco monopoly, and the Export-Import Bank of China, which will receive 30 billion yuan (€3.85bn).
Insurers squeezed from two directions
Insurers account for the remaining 70 billion yuan (€9bn). China Life Insurance Group, the country's largest life insurer, gets 35 billion yuan (€4.5bn) and China Taiping Insurance Group 7 billion yuan (€900mn). The People's Insurance Company of China plans to raise up to 15 billion yuan (€1.9bn) through a private placement to the ministry, China Export and Credit Insurance Corporation receives 10 billion yuan (€1.28bn), and China Reinsurance Group is raising 3 billion yuan (€385mn).
Insurers have been squeezed from two directions as years of low interest rates have eroded investment returns, while the government has directed them to put money into Chinese equities. The currency has been moving in the same direction. The Chinese yuan reached its strongest level against the US dollar since January 2023 on Monday, trading at around $0.149, a firmer exchange rate that also happens to blunt a long-standing American complaint about Chinese currency management, weeks before talks in Washington.
Beijing's busy month
The capital injection is not the only move Beijing is making this month. Chinese President Xi Jinping is reportedly preparing to bring a large delegation of business executives to his Washington visit on 24 September, according to sources cited by news agencies. It would be a notable departure from customary practice. Xi rarely travels with corporate leaders, many of whom lost standing after the regulatory crackdowns on technology, education and property that began in 2020, and the last comparable delegation accompanied him to the US more than a decade ago, in 2015.
Washington's response has also been curious. "The White House is not tracking a Chinese CEO delegation," a US official said, without explaining what tracking meant in this context, leaving the statement short of either confirmation or denial. The gesture would be reciprocal in any case. When US President Donald Trump visited Beijing in May, he brought a roster of American CEOs including Elon Musk, Tim Cook and Jensen Huang. Bringing Chinese counterparts to Washington would signal a willingness to invest and trade with the US, while handing the White House potential economic wins before November's midterm elections.
Expectations for the summit itself remain modest, with the two sides still divided over which products should count as non-sensitive under trade arrangements. For European observers, the injection is a reminder of how Beijing is using state resources to manage economic headwinds, a contrast with the EU's more fragmented approach to industrial policy. As the bloc debates its own budget priorities and raw materials strategy, the scale of China's state intervention underscores the competitive challenge.
